• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急性心肌梗死发病一个月后患者体内肝素可释放血小板因子4和D-二聚体增加:血小板及凝血/纤溶系统持续激活。

Increased heparin-releasable platelet factor 4 and D dimer in patients one month after the onset of acute myocardial infarction: persistent activation of platelets and the coagulation/fibrinolytic system.

作者信息

Abe S, Maruyama I, Arima S, Yamaguchi H, Okino H, Hamasaki S, Yamashita T, Nomoto K, Tahara M, Atsuchi Y

机构信息

First Department of Internal Medicine, Faculty of Medicine, Kagoshima University, Japan.

出版信息

Int J Cardiol. 1994 Dec;47(1 Suppl):S7-12. doi: 10.1016/0167-5273(94)90320-4.

DOI:10.1016/0167-5273(94)90320-4
PMID:7737755
Abstract

To evaluate the activity of platelets and the coagulation/fibrinolytic system 1 month after the onset of acute myocardial infarction, we measured the plasma levels of molecular markers, i.e. beta-thromboglobulin, platelet factor 4, thrombin-antithrombin III complex and D dimer, in 16 patients with acute myocardial infarction and in 11 normal subjects. Blood was drawn through a catheter placed in the pulmonary artery before heparin injection. The heparin-releasable platelet factor 4 was calculated by subtracting the level before the injection of 5000 U of heparin, from the level 5 min after injection. The plasma beta-thromboglobulin, thrombin-antithrombin III complex and the D dimer levels in the acute phase of myocardial infarction were 134.9 +/- 121.2, 11.2 +/- 7.1 and 164.4 +/- 115.3 ng/ml, respectively. These values were significantly higher than those in the normal subjects. The plasma levels of beta-thromboglobulin and thrombin-antithrombin III complex, 1 month after the onset (36.6 +/- 16.4 and 4.6 +/- 2.3 ng/ml, respectively) were not significantly different from those of the normal subjects. In contrast, D dimer and heparin-releasable platelet factor 4 were 216.9 +/- 176.9 and 80.5 +/- 29.3 ng/ml, respectively, and significantly higher than in the normal subjects. These findings suggest a latent but persistent activation of the platelets and the coagulation/fibrinolytic system 1 month after the onset of acute myocardial infarction.

摘要

为评估急性心肌梗死发病1个月后血小板及凝血/纤溶系统的活性,我们检测了16例急性心肌梗死患者和11名正常受试者血浆中分子标志物的水平,即β-血小板球蛋白、血小板第4因子、凝血酶-抗凝血酶III复合物及D-二聚体。在注射肝素前,通过置于肺动脉的导管采血。肝素可释放血小板第4因子通过注射5000 U肝素后5分钟时的水平减去注射前的水平来计算。心肌梗死急性期血浆β-血小板球蛋白、凝血酶-抗凝血酶III复合物及D-二聚体水平分别为134.9±121.2、11.2±7.1及164.4±115.3 ng/ml。这些值显著高于正常受试者。发病1个月后血浆β-血小板球蛋白及凝血酶-抗凝血酶III复合物水平(分别为36.6±16.4和4.6±2.3 ng/ml)与正常受试者无显著差异。相比之下,D-二聚体及肝素可释放血小板第4因子分别为216.9±176.9和80.5±29.3 ng/ml,显著高于正常受试者。这些发现提示急性心肌梗死发病1个月后血小板及凝血/纤溶系统存在潜在但持续的激活。

相似文献

1
Increased heparin-releasable platelet factor 4 and D dimer in patients one month after the onset of acute myocardial infarction: persistent activation of platelets and the coagulation/fibrinolytic system.急性心肌梗死发病一个月后患者体内肝素可释放血小板因子4和D-二聚体增加:血小板及凝血/纤溶系统持续激活。
Int J Cardiol. 1994 Dec;47(1 Suppl):S7-12. doi: 10.1016/0167-5273(94)90320-4.
2
Plasma and platelet plasminogen activator inhibitor-1 in patients with acute myocardial infarction.急性心肌梗死患者血浆及血小板中的纤溶酶原激活物抑制剂-1
Jpn Circ J. 2000 Aug;64(8):547-53. doi: 10.1253/jcj.64.547.
3
A comparative evaluation of assays for markers of activated coagulation and/or fibrinolysis: thrombin-antithrombin complex, D-dimer and fibrinogen/fibrin fragment E antigen.活化凝血和/或纤维蛋白溶解标志物检测方法的比较评估:凝血酶 - 抗凝血酶复合物、D - 二聚体和纤维蛋白原/纤维蛋白片段E抗原
Br J Haematol. 1990 Apr;74(4):471-9. doi: 10.1111/j.1365-2141.1990.tb06337.x.
4
Effects of direct percutaneous transluminal coronary angioplasty treatment of acute myocardial infarction on plasma levels of haemostatic and fibrinolytic factors.直接经皮腔内冠状动脉成形术治疗急性心肌梗死对血浆止血和纤溶因子水平的影响。
Blood Coagul Fibrinolysis. 1993 Oct;4(5):801-4.
5
Activation of coagulation system in dilated cardiomyopathy: comparison of patients with and without left ventricular thrombus.扩张型心肌病中凝血系统的激活:有和无左心室血栓形成患者的比较。
Coron Artery Dis. 2004 Aug;15(5):265-8. doi: 10.1097/01.mca.0000135596.54871.6f.
6
Activation of coagulation and fibrinolysis in patients with arteriosclerosis: relation to localization of vessel disease and risk factors.动脉硬化患者凝血和纤溶的激活:与血管疾病部位及危险因素的关系。
Thromb Res. 1990 Jul 1;59(1):77-88. doi: 10.1016/0049-3848(90)90273-f.
7
Age-based difference in activation markers of coagulation and fibrinolysis in extracorporeal membrane oxygenation.体外膜肺氧合中凝血和纤维蛋白溶解激活标志物的年龄差异。
Pediatr Crit Care Med. 2014 Jun;15(5):e198-205. doi: 10.1097/PCC.0000000000000107.
8
Clinical study of platelet function and coagulation/fibrinolysis with Duraflo II heparin coated cardiopulmonary bypass equipment.使用Duraflo II肝素涂层体外循环设备对血小板功能及凝血/纤溶的临床研究
ASAIO J. 1996 Jul-Aug;42(4):301-5.
9
Hemostatic abnormalities in acute myocardial infarction as detected by specific blood markers.通过特定血液标志物检测急性心肌梗死中的止血异常。
Thromb Res. 1994 Nov 1;76(3):289-98. doi: 10.1016/0049-3848(94)90200-3.
10
Thrombin generation as an acute effect of cigarette smoking.凝血酶生成作为吸烟的急性效应。
Am Heart J. 1994 Jul;128(1):7-11. doi: 10.1016/0002-8703(94)90003-5.

引用本文的文献

1
CXCL4 Plasma Levels Are Not Associated with the Extent of Coronary Artery Disease or with Coronary Plaque Morphology.CXCL4血浆水平与冠状动脉疾病的严重程度或冠状动脉斑块形态无关。
PLoS One. 2015 Nov 2;10(11):e0141693. doi: 10.1371/journal.pone.0141693. eCollection 2015.
2
Effective components of and protect the myocardium by inhibiting platelet activation and improving the hypercoagulable state.[具体物质名称1]和[具体物质名称2]的有效成分通过抑制血小板活化和改善高凝状态来保护心肌。
Exp Ther Med. 2015 Apr;9(4):1477-1481. doi: 10.3892/etm.2015.2271. Epub 2015 Feb 6.
3
Emphasis on the Role of PF4 in the Incidence, Pathophysiology and Treatment of Heparin Induced Thrombocytopenia.
强调 PF4 在肝素诱导的血小板减少症的发病机制、病理生理学和治疗中的作用。
Thromb J. 2013 Apr 5;11(1):7. doi: 10.1186/1477-9560-11-7.
4
Diagnostic value of D-dimer measurement in patients referred to the emergency department with suspected myocardial ischemia.D - 二聚体检测在因疑似心肌缺血而转诊至急诊科的患者中的诊断价值。
J Thromb Thrombolysis. 2008 Jun;25(3):247-50. doi: 10.1007/s11239-007-0060-6. Epub 2007 Jun 1.